Clinical Trials for Congenital Erythropoietic Porphyria (CEP)

A Study to Investigate the Improvement of Photosensitivity in Terms of Skin Lesions Associated With CEP Following Administration of Oral ATL-001 (Ciclopirox Oral Solution) in Participants Aged >18 Years of Age With CEP

NCT ID: NCT07024316

This clinical trial is studying a new oral medication called ATL-001 (ciclopirox) to see if it can help improve skin problems and other symptoms caused by a rare condition called Congenital Erythro...